浏览全部资源
扫码关注微信
1.中国中医科学院 西苑医院,北京 100091
2.中国中医科学院 研究生院,北京 100029
吕妍,硕士,主治医师,从事中西医结合血液病研究,E-mail:lvyan060809@163.com
唐旭东,博士,主任医师,硕士生导师,从事中西医结合血液病研究,Email:tangxudong001@163.com
收稿日期:2022-07-13,
网络出版日期:2023-02-10,
纸质出版日期:2023-07-20
移动端阅览
吕妍,李芮,唐旭东.补肾生血法和益气养血法治疗再生障碍性贫血的血常规变化规律比较及分阶段治疗模式[J].中国实验方剂学杂志,2023,29(14):73-79.
LYU Yan,LI Rui,TANG Xudong.Comparison of Blood Routine Changes in Treatment of Aplastic Anemia by Kidney-tonifying and Blood-generating Method and Qi-promoting and Blood-nourishing Method and Mode of Treatment by Stages[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(14):73-79.
吕妍,李芮,唐旭东.补肾生血法和益气养血法治疗再生障碍性贫血的血常规变化规律比较及分阶段治疗模式[J].中国实验方剂学杂志,2023,29(14):73-79. DOI: 10.13422/j.cnki.syfjx.20230701.
LYU Yan,LI Rui,TANG Xudong.Comparison of Blood Routine Changes in Treatment of Aplastic Anemia by Kidney-tonifying and Blood-generating Method and Qi-promoting and Blood-nourishing Method and Mode of Treatment by Stages[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(14):73-79. DOI: 10.13422/j.cnki.syfjx.20230701.
目的
2
探讨补肾生血和益气养血法联合西药治疗再生障碍性贫血临床疗效及血常规恢复特征,探索分阶段治疗再生障碍性贫血新模式。
方法
2
此项研究来源于一项前瞻性、多中心、双盲、随机对照临床试验,分析了19个中心的再生障碍性贫血患者,分为补肾生血组、益气养血组予以中药联合西药治疗,评价临床疗效及各组治疗过程中血常规变化规律。
结果
2
观察期间共入组375例再生障碍性贫血患者,中医辨证均同时符合肾虚和气血两虚型,随机分为2组,其中补肾生血组184例,益气养血组191例,中药治疗分别予以补肾生血方颗粒剂及益气养血方颗粒剂,均联合口服雄激素及环孢素软胶囊。治疗共6个月,分为3个阶段:从治疗开始到第1个月末、第4个月末和第6个月末进行访视。6个月后评价疗效,补肾生血组总有效率86.4%(159/184),明显优于益气养血组的68.6%(131/191,
P
<
0.01)。分析2组患者各阶段血细胞增长幅度百分比四分位数结果,补肾生血组患者血红蛋白浓度和血小板计数在治疗后持续增长,与第一阶段比较,第二阶段和第三阶段显著增长(
P
<
0.05);网织红细胞计数增长幅度在治疗第一阶段最为显著(
P
<
0.05)。益气养血组患者的网织红细胞计数在治疗第一、第二阶段均有显著增长(
P
<
0.05)。其余观察指标各阶段均有增长但增长幅度无统计学差异。分阶段对比2组疗效,在治疗第二阶段,补肾生血组的血红蛋白浓度增长幅度优于益气养血组(
P
<
0.05);益气养血组血小板计数和红细胞计数增长幅度更大(
P
<
0.05);治疗第三阶段,补肾生血组血红蛋白浓度增长幅度更明显(
P
<
0.05)。
结论
2
补肾生血法治疗再生障碍性贫血总体有效率优于益气养血法,临床疗效确切,安全有效;该研究提出三阶段论治再障的早期治疗模式,治疗第一、第三阶段(0~1、5~6个月)采取补肾生血法为主;治疗第二阶段(2~4个月)采用补肾生血法结合益气养血法,可能更贴近再生障碍性贫血的临床实际治疗反应和客观规律变化。
Objective
2
To explore the clinical effect of kidney-tonifying and blood-generating method and qi-promoting and blood-nourishing method combined with western medicine on the treatment of aplastic anemia and the characteristics of blood routine recovery, and to explore a new phased treatment model for aplastic anemia.
Method
2
This study was based on a prospective, multicenter, double-blind, and randomized controlled clinical trial. Patients with aplastic anemia from 19 centers were analyzed and divided into a kidney-tonifying and blood-generating group and a Qi-promoting and blood-nourishing group, which were treated with traditional Chinese medicine (TCM) combined with western medicine. The clinical effect and the changes in blood routine in each group during treatment were evaluated.
Result
2
During the observation period, 375 cases of aplastic anemia were included in two groups, and TCM syndrome differentiation conformed these cases as Qi-deficiency type and both Qi and blood-deficiency type. These cases were randomly divided into two groups, including 184 in the kidney-tonifying and blood-generating group and 191 in the Qi-promoting and blood-nourishing group, being treated by kidney-tonifying and blood-generating granules and Qi-promoting and blood-nourishing granules, respectively, and combined oral androgen and ciclosporin soft capsules. The treatment lasted for six months and was divided into three stages. Visits were conducted from the beginning of the treatment to the end of the first, fourth, and sixth months. The curative effect was evaluated six months later. The total effective rate of the kidney-tonifying and blood-generating group was 86.4% (159/184), which was significantly better than that of the Qi-promoting and blood-nourishing group [68.6% (131/191),
P
<
0.01)]. The results of the percentage quartile of blood cell growth in each stage of the 2 groups were analyzed. The hemoglobin concentration and platelet count of the patients in the kidney-invigorating blood group continued to increase after treatment
and significantly increased in the second and third stages compared with the first stage (
P
<
0.05). The increase of reticulocyte count was most significant in the first stage of treatment (
P
<
0.05). The reticulocyte count in supplementing Qi and nourishing blood group increased significantly in the first and second stages of treatment (
P
<
0.05). The other observation indicators increased at each stage
but there was no statistical difference in the growth rate. The effects of the two groups were compared by stages. In the second stage of treatment
the increase of hemoglobin concentration in the kidney-invigorating blood group was better than that in the supplementing Qi-nourishing blood group (
P
<
0.05). The increase of platelet count and red blood cell count in supplementing Qi and nourishing blood group was greater (
P
<
0.05). In the third stage of treatment
the increase of hemoglobin concentration in the bushen Shengxue group was more significant (
P
<
0.05).
Conclusion
2
The overall effective rate of the kidney-tonifying and blood-generating method in the treatment of aplastic anemia is better than that of the Qi-promoting and blood-nourishing method, with significant effects and safety. This study has proposed a three-stage early treatment mode for aplastic anemia. The first and third stages (0-1
5-6 months) were mainly treated by invigorating kidney and generating blood. In the second stage of treatment (2-4 months)
invigorating kidney and generating blood combined with invigorating Qi and nourishing blood were adopted. It may be closer to the actual clinical treatment response and objective rule changes of aplastic anemia.
中华医学会血液学分会红细胞疾病(贫血)学组 . 再生障碍性贫血诊断与治疗中国专家共识 [J]. 中华血液学杂志 , 2017 , 38 ( 1 ): 1 - 5 .
ALLY M , MAGESA P , LUZZATTO L . High frequency of acquired aplastic anemia in Tanzania [J]. Am J Hematol , 2019 , 94 ( 4 ): E86 - E88 .
MARSH J C . Treatment of aplastic anaemia:First do no harm [J]. Lancet , 2000 , 356 ( 9241 ): 1536 - 1537 .
BACIGALUPO A . How I treat acquired aplastic anemia [J]. Blood , 2017 , 129 ( 11 ): 1428 - 1436 .
MELINKERI S R . Epidemiology,pathogenesis and diagnosis of aplastic anaemia [J]. J Assoc Physicians India , 2015 , 63 ( 3 Suppl ): 8 - 12 .
刘永华 , 江锦红 , 吴迪炯 , 等 . 补肾活血法与益气补肾法治疗慢性再生障碍性贫血的疗效比较 [J]. 中国中西医结合急救杂志 , 2015 , 22 ( 3 ): 234 - 238 .
KIM S Y , LEE J W , LEE S E , et al . The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis [J]. Genes Chromosomes Cancer , 2010 , 49 ( 9 ): 844 - 850 .
SHIN S H , YOON J H , YAHNG S A , et al . The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: A single-center retrospective study [J]. Ann Hematol , 2013 , 92 ( 6 ): 817 - 824 .
陈信义 , 陈珮 . 中医治疗血液病名家学术观点撷菁 [J]. 北京中医药 , 2021 , 40 ( 5 ): 466 - 469 .
陈信义 , 麻柔 , 李冬云 . 规范常见血液病中医病名建议 [J]. 中国中西医结合杂志 , 2009 , 29 ( 11 ): 1040 - 1041 .
沈悌 , 赵永强 . 血液病诊断及疗效标准第4版 [M]. 北京 : 科学出版社 , 2018 : 4 .
沈自尹 , 王文健 . 中医虚证辨证参考标准 [J]. 中国中西医结合杂志 , 1986 ( 10 ): 598 - 598 .
阳正国 . 中医对再生障碍性贫血病因病机的认识及治疗现状 [J]. 中医药导报 , 2012 , 18 ( 1 ): 86 - 87 .
陈艳鑫 , 杨文华 , 杨向东 . 致重慢性再生障碍性贫血的中医因素探析 [J]. 黑龙江中医药 , 2012 , 41 ( 2 ): 2 - 4 .
任莉 . 补脾益肾法治疗血液病举隅 [J]. 浙江中医杂志 , 2012 , 47 ( 3 ): 214 - 215 .
全日城 , 郭小青 , 胡乃平 , 等 . 首都国医名师大师1+1丛书周霭祥血液病诊治思想及临证集萃 [M]. 北京 : 北京科学技术出版社 , 2021 : 2 .
0
浏览量
36
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构